SCHEMBL26592002

SCHEMBL26592002

N#Cc1ccccc1-c1cccc(-c2nc(-c3ccc(-c4ccccc4)cc3)nc(-c3cc(-c4ccccc4)ccc3-c3ccccc3)n2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR2 Q92731 1/20 0.44
▸ TRPA1 O75762 1/20 0.44
▸ GABRG2 P18507 6/20 0.43
▸ GABRB3 P28472 6/20 0.43
▸ GABRA5 P31644 4/20 0.43
▸ GABRA3 P34903 4/20 0.43
▸ GABRA1 P14867 5/20 0.42
▸ GABRA2 P47869 4/20 0.42
▸ CYP11B1 P15538 1/20 0.40
▸ CYP11B2 P19099 1/20 0.40
▸ ALOX5AP P20292 1/20 0.39
▸ FEN1 P39748 1/20 0.39
▸ CYP19A1 P11511 1/20 0.39
▸ GRM5 P41594 1/20 0.39
▸ USP30 Q70CQ3 1/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ NR3C1 P04150 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27368560 1.00 ESR2 (0.44) ESR2TRPA1GABRG2GABRB3GABRA5
SCHEMBL27368552 0.96 ESR2 (0.43) ESR2TRPA1GABRG2GABRB3GABRA5
SCHEMBL26592006 0.95 TRPA1 (0.45) ESR2TRPA1GABRG2GABRB3GABRA5
SCHEMBL27368467 0.95 ESR2 (0.44) ESR2TRPA1GABRG2GABRB3GABRA5
SCHEMBL26277281 0.95 ESR2 (0.46) ESR2TRPA1GABRG2GABRB3GABRA5
SCHEMBL26591999 0.94 TRPA1 (0.43) ESR2TRPA1GABRG2GABRB3GABRA5
SCHEMBL26592014 0.94 TRPA1 (0.46) ESR2TRPA1GABRG2GABRB3GABRA5
SCHEMBL26277284 0.93 ESR2 (0.45) ESR2TRPA1GABRG2GABRB3GABRA5
SCHEMBL26276246 0.93 TRPA1 (0.47) ESR2TRPA1GABRG2GABRB3GABRA5
SCHEMBL27453620 0.93 ESR2 (0.47) ESR2TRPA1GABRG2GABRB3GABRA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230337532-A1 TRIAZINE COMPOUND, MATERIAL FOR ORGANIC LIGHT EMITTING DIODE, ELECTRON TRANSPORT MATERIAL FOR ORGANIC LIGHT EMITTING DIODE, AND ORGANIC LIGHT EMITTING DIODE TOSOH CORPORATION (JP) 2023-10-19 — — US disclosed
US-20230337532-A1 TRIAZINE COMPOUND, MATERIAL FOR ORGANIC LIGHT EMITTING DIODE, ELECTRON TRANSPORT MATERIAL FOR ORGANIC LIGHT EMITTING DIODE, AND ORGANIC LIGHT EMITTING DIODE TOSOH CORPORATION (JP) 2023-10-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230337532-A1 TRIAZINE COMPOUND, MATERIAL FOR ORGANIC LIGHT EMITTING DIODE, ELECTRON TRANSPORT MATERIAL FOR ORGANIC LIGHT EMITTING DIODE, AND ORGANIC LIGHT EMITTING DIODE ARNT, TPH1, AHR ESR2 174/4885TRPA1 50/4885GABRG2 4314/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback